secwatch.observer — SEC 8-K summary
======================================

Issuer:     Olema Pharmaceuticals, Inc. (OLMA)
CIK:        0001750284
Form:       8-K
Filed at:   2025-01-13T23:59:59+00:00
Accession:  0000950170-25-004563
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Olema Pharmaceuticals makes investor presentation available; no specific facts disclosed
--------------------------------------------------------------------------------

- Company filed Form 8-K with investor presentation dated January 13, 2025.
- Presentation content not provided; no new financial or clinical data reported.
- No material updates on pipeline, earnings, or corporate events available from filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1750284/000095017025004563/0000950170-25-004563-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1750284/000095017025004563/olma-20250113.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-004563

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer